Chen Jiang

6.9k citations
78 papers · 5.8k indexed · 2 hit papers · h-index 41

Impact in

Papers in

Chen Jiang

77 papers receiving 5.7k citations

Hit Papers

Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment 2020 · 356 citations
3562018202620202023100200300

Peers

Chen Jiang
Comparison fields: 5 of 128
  • Biomaterials 2.3k
  • Pharmaceutical Science 427
  • Molecular Biology 3.2k
  • Polymers and Plastics 609
  • Biomedical Engineering 1.9k
Replace Khuloud T. Al‐Jamal with:
Khuloud T. Al‐Jamal United Kingdom
Sun Hwa Kim South Korea
Ronit Satchi‐Fainaro Israel
Meng Zheng China
Yu Matsumoto Japan
Inge S. Zuhorn Netherlands
Junjie Liu China
Gaurav Sahay United States
Chung Hang Jonathan Choi Hong Kong
Bing He China
Chen Jiang relative to Khuloud T. Al‐Jamal United Kingdom Khuloud T. Al‐Jamal's profile →
Citations per field
00.5×1.5×
Khuloud T. Al‐Jamal · 1×
Citations per year

Countries citing papers authored by Chen Jiang

Since Specialization
Citations

This map shows the geographic impact of Chen Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Jiang more than expected).

Fields of papers citing papers by Chen Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Jiang. The network helps show where Chen Jiang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chen Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chen Jiang Line = papers co-authored together Chen Jiang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 202249
3 202214
4
Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
Hit paper breakdown →
2020356
5 202081
6 201931
7 2019129
8 201828
9 201712
10 201695
11 201543
12 201525
13 201417
14 201357
15
Template-directed Synthesis of a Novel Oxalate Compound [Co(dien)2][NaCo2(C2O4)4] Using Co(III) Complex as Template
20111
16 201090
17 2009214
18 200959
19
Human Peripheral Blood Mononuclear Cell Proteome Analysis of Parkinson Disease with Different TCM Syndromes
20082
20 2007123

About Chen Jiang

Chen Jiang is a scholar working on Biomaterials, Polymers and Plastics, Molecular Biology, Cancer Research and Biomedical Engineering, having authored 78 papers that have together received 5.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (34 papers), Nanoparticle-Based Drug Delivery (33 papers), Nanoplatforms for cancer theranostics (22 papers), Advanced biosensing and bioanalysis techniques (17 papers), Dendrimers and Hyperbranched Polymers (9 papers), Molecular Sensors and Ion Detection (5 papers), MicroRNA in disease regulation (5 papers) and Graphene and Nanomaterials Applications (4 papers). The work is most often cited by research in Biomaterials (2.3k citations), Pharmaceutical Science (427 citations), Molecular Biology (3.2k citations), Polymers and Plastics (609 citations) and Biomedical Engineering (1.9k citations). Chen Jiang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Rongqin Huang, Tao Sun, Liang Han, Yujie Zhang, Weilun Ke, Xi He, Kun Shao, Jianfeng Li, Shixian Huang and Yuyang Kuang. Their work appears in journals such as Biomaterials, ACS Applied Materials & Interfaces, Acta Pharmaceutica Sinica B, Journal of Controlled Release and Molecular Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026